Melinta Therapeutics

VABOMERE

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Melinta Therapeutics

Vabomere HCPCS:

J2186

HCPCS Code Descriptor:

Injection, meropenem and vaborbactam, 10mg/10mg (20mg)

Category:

J Code

Vabomere NDCs:

70842-0120-06

Primary Type:

Antibiotic

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Vabomere CPT Codes:

Potential CPT administration codes for Vabomere can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

70842-0120-06

About Vabomere:

VABOMERE is an Antibiotic drug manufactured by Melinta Therapeutics and administered via the Intravenous route of administration. The J Code: J2186 is aligned to the drug VABOMERE.

ACCESS PRICING AND MORE BY REGISTERING

J2186 Added Date:

January 1, 2019

J2186 Effective Date:

January 1, 2019

J2186 Termination Date:

HCPCS Active

Vabomere billing and coding information can be found through Melinta Therapeutics at the link below:
Our team did not identify a source for Vabomere patient assistance information. Please reach out to our team if you feel that this is a mistake.
VABOMERE prescribing information can be found at the link below:
Information regarding VABOMERE’s side effects can be found at MedlinePlus